Cell and Gene at AbbeyCell and Gene at the Abbey

Production, Scale-up and Global Harmonisation

Conference Agenda

DAY 01: 10TH NOVEMBER 2021
TIME SPEAKER COMPANY TITLE OF TALK
09.00 Aoife Duffy / Brian Harrison HiTech Health Introduction and Update on HTH Cell & Gene Therapy Programme
09.15 Prof. Francesco Curcio University of Udine Clinical use of MSCs: the experience at the University of Udine Medical Centre.
10.00 Scott Olsen University of Texas Developing Potency Measures of MSC and MSC-like Products.
10.45 COFFEE
11.15 Shirley O'Dea Avectas Solupore Non-viral Cell Engineering Platform.
12.00 Brian O’ Connor Meira GTx Challenges in Viral Vector Manufacture & Processes.
12.45 LUNCH
14.00 Qasim Rafiq UCL Automated Process Development and Manufacturing Strategies for ATMPs.
14.45 Mandana Haack-Sørensen Rigshospitalet Automation of cell therapy manufacturing: Lessons learned on compliance, product quality and production consistency.
15.30 COFFEE
16.00 Benjamin Gysi / Áine Adams Takeda Pharmaceutical Update on Takeda´s Cell Therapy Strategy Development.
18.00 Drinks Reception
19.30 Dinner @ Glenlo Sponsored by AccuScience
DAY 02: 11TH NOVEMBER 2021
TIME SPEAKER COMPANY TITLE OF TALK
09.00 Bruce Levine UPenn Development, Regulatory Approval, and Improvements in Engineered T Cell Therapies.
09.45 Massimo Dominici University Hospital of Modena and Reggio Emilia Modena, Italy Scaling up anti-cancer gene therapies: challenges and opportunities.
10.30 COFFEE
11.00 Prof. Garry Duffy NUIG Ambient Cell Transport and Implant Delivery Using Device and Biomaterial Approach.
11.45 Bernd Kullman Sigilon Therapeutics ATMP Manufacturing, Release, and Distribution: establishing a supply network and reducing risk for a time and temperature sensitive product.
12.30 LUNCH
13.45 Róisín O'Cearbhaill Memorial Sloan Kettering Overcoming challenges of cellular therapies in solid tumours.
14.30 Knut Niss MustangBio From MSCs to CARTs: How Manufacturing of ATMPs changed over the Last Decade.
15.15 COFFEE
15.30 Workshop
18.30 Dinner in The Galmont Sponsored by Meira GTx.
DAY 03: 12TH NOVEMBER 2021
TIME SPEAKER COMPANY TITLE OF TALK
09.00 Niamh Curran HPRA ATMPs- a regulatory update and lessons learned so far.
09.45 Nisha Durand Mayo Clinic Insights into the Operations of a small cGMP Cell Therapy Manufacturing Facility in an Academic Setting.
10.30 Patrick Hanley Children’s National Hospital, The George Overcoming Challenges in the Cellular Therapy Laboratory.
11.15 COFFEE
11.45 Michael O’Dwyer ONK Therapeutics Fundraising as a CGT start up: The agony and the ecstasy!
12.30 Jim Faulkner / Michael O’Dwyer Venture Partner / ONK Therapeutics Investing in Advanced Therapies.
13.15 LUNCH

Fee & Cancellation Policy

Rate includes 2.5 days conference attendance with workshop on Day 2, coffees, lunches, a drinks reception and 2 dinners. 

 

Early Bird Registration, before April 30th, 2021
[SALES ENDED]

€1,250 per attendee 

2 or more from one company €1,000 per attendee 

 

General Registration, after May 01st, 2021
[NOW AVAILABLE]

€1,500 per attendee 

2 or more from one company €1,250 per attendee 

 

Academic rate available upon request.

Cancellation possible until September 30th subject to a €100.00 cancellation fee.

Registration

Accommodation

Accommodation is available at the Glenlo Abbey Hotel, and can be booked directly via the hotel or via e-mail at reservation@glenloabbey.ie using promo-codeHiTechHealth’. Special rate of 160 B&B single or 170 for Twin or Double.

In addition, rooms are also available at the Harbour Hotel (www.harbour.ie located in Galway City. Bookings can be made directly via the hotel or via e-mail at reservations@harbour.ie using promo-code ‘HiTechHealth. Special rate of €129 B&B single or €139 for Twin or Double. Transfer will be organised for attendees staying in this hotel to the venue each morning of the meeting.

2023 ATMP Review

The Advanced Therapeutic Medicinal Products (ATMPs) sector is evolving rapidly and new products have already demonstrated the ability to reverse or significantly impact the progression of disease. In recent years, the advent of cell and gene therapies has shown the...

Stay Up To Date

Connect with us to receive the latest HiTech Health and industry updates.